Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06340646 · ClinicalTrials.gov registry record · NA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
A NA study of Multiple Myeloma and Colon Cancer, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 990
- Enrollment target
- 1
- Study location
NCT06340646 is a NA study of Multiple Myeloma and Colon Cancer that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 990 participants, above the 545-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (82% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06340646, a NA study of Multiple Myeloma and Colon Cancer, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 990 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding returning of genomic results on participants' health and satisfaction. Participants in this study will be presented with the choice of types of genomic results to receive, and the Engagement Optimization Unit (EOU) will investigate the impact of this intervention on participant knowledge, expectations of benefit, personal utility, and decisional conflict.
Conditions Studied
Interventions
- OTHER Return of Genetic Results: Biomarker information from cancer cells
- OTHER Return of Genetic Results: Inherited mutations related to cancer
- OTHER Return of Genetic Results: Inherited mutations related to other medical issues
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 990 participants |
| Start Date | 2022-10-18 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06340646
The ClinicalTrials.gov registry entry for NCT06340646 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 990 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 545-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (82% higher). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Multiple Myeloma appearing as the primary indexed condition, and to 3 interventions - of which Return of Genetic Results: Biomarker information from cancer cells is the first listed.
NCT06340646 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06340646 about?
NCT06340646 is a clinical study titled "Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)". The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding r...
What is the current status of trial NCT06340646?
This trial is currently recruiting. It is a NA study. The enrollment target is 990 participants. The study started on 2022-10-18. Estimated completion is 2027-01-31.
What conditions does trial NCT06340646 study?
This clinical trial studies the following conditions: Multiple Myeloma, Colon Cancer, Rectal Cancer, Cholangiocarcinoma.
What interventions are being tested in trial NCT06340646?
The interventions under investigation include: Return of Genetic Results: Biomarker information from cancer cells (OTHER), Return of Genetic Results: Inherited mutations related to cancer (OTHER), Return of Genetic Results: Inherited mutations related to other medical issues (OTHER).
Who is sponsoring clinical trial NCT06340646?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06340646 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
RECRUITING · NA
-
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
RECRUITING · NA
-
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
RECRUITING · NA
-
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation
RECRUITING · NA
-
Prehabilitation Feasibility Among Older Adults Undergoing Transplantation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.